CHARACTERIZATION OF CEFTRIAXONE-RESISTANT ENTEROBACTERIACEAE - A MULTICENTER STUDY IN 26 FRENCH HOSPITALS

被引:51
作者
GOLDSTEIN, FW
PEAN, Y
ROSATO, A
GERTNER, J
GUTMANN, L
机构
[1] UNIV PARIS,HOP INT,BACTERIOL LAB,F-75014 PARIS,FRANCE
[2] HOP BROUSSAIS,MICROBIOL MED LAB,F-75674 PARIS 14,FRANCE
关键词
D O I
10.1093/jac/32.4.595
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
During a multicentre study performed in 26 French hospitals, 287 (3·2%) of 9038 Enterobacteriaceac isolated, mainly Enterobacter spp., Serratia spp., Citrobacter spp. and Kiebsiella spp. were classified as ceftriaxone resistant on the basis of an MIC >4 mg/L or the presence of an extended-spectrum β-lactamase. Extended-spectrum β-lactamase was present mainly in Kiebsiella pneumoniae (65 strains, 10·2%) and very rarely in Escherichia coli, Proteus mirabilis, Klebsiella oxytoca, Citrobacter spp. and Enterobacter spp. The extended-spectrum β-lacta mases conferred low-level resistance to ceftriaxone in nearly 60% of the strains harbouring them, emphasizing the need for routine testing for the presence of these enzymes. Among transconjugants three types of extended-spectrum β-lactamase were identified. Those resembling TEM-3 were the most common, but TEM-21, and SHV-4 were also found. Clavulanate and to a lesser extent sulbactam inhibited all the extended-spectrum β-lactamases encountered in this study. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:595 / 603
页数:9
相关论文
共 17 条
[1]  
ACAR J, 1991, PATHOL BIOL PARIS, V39, P737
[2]   OUTBREAK OF NOSOCOMIAL INFECTIONS DUE TO KLEBSIELLA-PNEUMONIAE PRODUCING SHV-4 BETA-LACTAMASE [J].
ARLET, G ;
SANSONLEPORS, MJ ;
ROUVEAU, M ;
FOURNIER, G ;
MARIE, O ;
SCHLEMMER, B ;
PHILIPPON, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (11) :797-803
[3]  
BRUNBUISSON C, 1987, LANCET, V2, P302
[4]   SHV-5, A NOVEL SHV-TYPE BETA-LACTAMASE THAT HYDROLYZES BROAD-SPECTRUM CEPHALOSPORINS AND MONOBACTAMS [J].
GUTMANN, L ;
FERRE, B ;
GOLDSTEIN, FW ;
PINTOSCHUSTER, E ;
ACAR, JF ;
COLLATZ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :951-956
[5]   MORE EXTENDED-SPECTRUM BETA-LACTAMASES [J].
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1697-1704
[6]  
JARLIER V, 1988, REV INFECT DIS, V10, P867
[7]   DISSEMINATION OF THE NOVEL PLASMID-MEDIATED BETA-LACTAMASE CTX-1, WHICH CONFERS RESISTANCE TO BROAD-SPECTRUM CEPHALOSPORINS, AND ITS INHIBITION BY BETA-LACTAMASE INHIBITORS [J].
KITZIS, MD ;
BILLOTKLEIN, D ;
GOLDSTEIN, FW ;
WILLIAMSON, R ;
NHIEU, GTV ;
CARLET, J ;
ACAR, JF ;
GUTMANN, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (01) :9-14
[8]   EVOLUTION OF PLASMID-CODED RESISTANCE TO BROAD-SPECTRUM CEPHALOSPORINS [J].
KLIEBE, C ;
NIES, BA ;
MEYER, JF ;
TOLXDORFFNEUTZLING, RM ;
WIEDEMANN, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) :302-307
[9]   TRANSFERABLE RESISTANCE TO CEFOTAXIME, CEFOXITIN, CEFAMANDOLE AND CEFUROXIME IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE AND SERRATIA-MARCESCENS [J].
KNOTHE, H ;
SHAH, P ;
KRCMERY, V ;
ANTAL, M ;
MITSUHASHI, S .
INFECTION, 1983, 11 (06) :315-317
[10]   DETECTION OF EXTENDED BROAD-SPECTRUM BETA-LACTAMASES IN ENTEROBACTERIACEAE IN 4 FRENCH HOSPITALS [J].
LEGRAND, P ;
FOURNIER, G ;
BURE, A ;
JARLIER, V ;
NICOLAS, MH ;
DECRE, D ;
DUVAL, J ;
PHILIPPON, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (06) :527-529